Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT
The Vanguard Group reported a 7.89% stake in Rocket Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group reported a 7.89% stake in Rocket Pharmaceuticals, Inc., 8,544,423 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 7.89%
- Shares
- 8,544,423
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 7.89% | 8,544,423 |
Source
Related
- Rocket Pharmaceuticals, Inc.
- The Vanguard Group
- Rocket Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Wilson Martin · Sep 15, 2026
- Form 4 · Wilson Martin · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 20, 2026
- Form 4 · Shah Gaurav · Aug 17, 2026
- Form 4 · Wilson Martin · Aug 17, 2026